IPH4502
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IPH4502, covering 2026-01-07 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors [Phase 1]